BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,000 | -99.1% | 348 | -99.3% | 0.00% | -100.0% |
Q4 2021 | $668,000 | -94.6% | 48,241 | -94.4% | 0.00% | -95.8% |
Q3 2021 | $12,475,000 | +5.6% | 868,137 | +16.2% | 0.02% | +9.1% |
Q2 2021 | $11,810,000 | +4568.0% | 746,971 | +2898.2% | 0.02% | – |
Q1 2021 | $253,000 | +25200.0% | 24,914 | +15091.5% | 0.00% | – |
Q4 2020 | $1,000 | -99.9% | 164 | -100.0% | 0.00% | -100.0% |
Q3 2019 | $949,000 | -58.8% | 331,172 | -45.6% | 0.00% | -66.7% |
Q2 2019 | $2,306,000 | -63.7% | 608,316 | -22.0% | 0.01% | -62.5% |
Q1 2019 | $6,344,000 | +80.2% | 779,406 | +78.7% | 0.02% | +60.0% |
Q4 2018 | $3,520,000 | +31900.0% | 436,137 | +31481.2% | 0.01% | – |
Q3 2018 | $11,000 | -97.1% | 1,381 | -98.0% | 0.00% | -100.0% |
Q2 2017 | $385,000 | -81.8% | 69,320 | -72.5% | 0.00% | -83.3% |
Q1 2017 | $2,117,000 | +298.7% | 252,060 | +200.7% | 0.01% | +200.0% |
Q4 2016 | $531,000 | +48.7% | 83,835 | +3.7% | 0.00% | +100.0% |
Q3 2016 | $357,000 | +20.2% | 80,852 | -22.7% | 0.00% | 0.0% |
Q2 2016 | $297,000 | +2870.0% | 104,574 | +10357.4% | 0.00% | – |
Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |